Table 1.
Description of the study cohorta
| oGTT group | All (N = 595) | Control ( N = 251) | IFG ( N = 193) | IGT ( N = 26) | IFG + IGT ( N = 68) | T2D ( N = 57) |
|---|---|---|---|---|---|---|
| Male | 380 | 140 | 130 | 18 | 45 | 47 |
| Female | 215 | 111 | 63 | 8 | 23 | 10 |
| Age [years] | 54.3 ± 8.9 | 52.8 ± 10.1 | 54.6 ± 7.9 | 57.2 ± 7.7 | 56 ± 8.1 | 56.4 ± 7.0 |
| BMI [kg/m2] | 28.8 ± 4.1 | 27.9 ± 4.0 | 29.0 ± 3.8 | 29.4 ± 3.5 | 30.3 ± 4.3 | 30.4 ± 4.3 |
| HbA1c [%] | 5.9 ± 0.4 | 5.8 ± 0.2 | 5.9 ± 0.3 | 5.9 ± 0.4 | 6 ± 0.3 | 6.3 ± 0.7 |
| FindRisk Score [a.u] | 12.5 ± 3.6 | 11.4 ± 3.8 | 12.9 ± 3.3 | 12.7 ± 2.8 | 14 ± 3.0 | 13.7 ± 3.4 |
| c ( t = 0)a [mg/dL] | 103.4 ± 13.4 | 93.8 ± 4.7 | 106.7 ± 5.6 | 95.2 ± 3.9 | 109.9 ± 6.6 | 130.3 ± 18.8 |
| c (t = 120)b [mg/dL] | 122.1 ± 43.6 | 101.2 ± 20.6 | 106.2 ± 20.3 | 155.3 ± 14.6 | 163.8 ± 17.2 | 210.9 ± 61.4 |
aConcentration of glucose in the oGTT at t = 0 min
bConcentration of glucose in the oGTT at t = 120 min